filmov
tv
PARAGON-HF: Is There a Role for the ARNI in HFpEF?
Показать описание
PARAGON-HF: Is There a Role for the ARNI in HFpEF?
ESC 2019 Expert Discussion: PARAGON-HF-Prof Scott Solomon And Prof Carolyn Lam
PARAGON HF Trial
PARAGON-HF: debate about HFpEF is wide open
Sacubitril/Valsartan and Frailty in HFpEF in PARAGON-HF | ESC Congress 2022
La SEC te lleva a AHA19 [IN] ∙ PARAGON-HF: Effects of Sacubitril/Valsartan in Women
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial
ESC 2022: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF & HFpEF
DAPA HF & PARAGON HF A Tale of Two Diseases - Dr. Amr Gamal Shawky
Carolyn S. P. Lam | Heart Failure with Preserved Ejection Fraction HFpEF: Past, Present, Future
ESC TV at ESC Congress 2019 - PARAGON-HF (Investigator)
ESC TV at ESC Congress 2019 - Meet the Trialist - PARAGON-HF
Ε. Tsougkos | From PARADIGM to PARAGON: Is there any evidence for continuity into the HF spectrum?
ESC 2019: Primary Results Of The PROVE-HF Study - Harriette Van Spall And James Januzzi
E. Petropoulou | From PARADIGM to PARAGON: Is there any evidence for continuity into the HF spect...
praragon - HF Trial is it really a paragon - Dr- Mohamed Adel Abdelwhab
HFSA 2022: PROVE-HF: Effect of Sacubitril/Valsartan in HFrEF Pts With MR | Dr James L Januzzi
GALACTIC-HF Results
PARAGON-HF: importanti segnali verso la fenotipizzazione per il trattamento dello HFpEF
Keynote Presentation: Changing Paradigms of Heart Failure (Javed Butler, MD)
Sacubitril / Valsartan (neprilysin inhibitor)
ESC 2019: PARAGON HF, Salt Substitution, POPular Genetics, DAPA-HF
HFA 2020: HFpEF and structural heart disease — Prof David Playford
Heart Failure with Preserved Ejection Fraction (HFpEF), by Mariana Lamacié, MD, MSc, FRCPC
Комментарии